Pharmacia company was founded in 1911 in Stockholm, Sweden by pharmacist Gustav Felix Grönfeldt at the Elgen Pharmacy. The company is named after the Greek word φαρμακεία, transliterated pharmakeia, which means 'sorcery'. In the company's early days, much of its profits were derived from the "miracle medicine" Phospho-Energon.
Pfizer Inc and Pharmacia Corporation began operating as a unified company on April 16, 2003, forging one of the world's fastest-growing and most valuable companies. With a research and development budget of $7.1 billion in 2003, the new Pfizer is now the world's leading research-based pharmaceutical company.
People also ask
What is Pharmacia company?
Who started Pharmacia Corporation?
When did Pharmacia merge with Pfizer?
When was Pharmacia founded?
Pharmacia is a peer-reviewed multidisciplinary medical journal devoted to pharmaceutical and allied sciences.
a healthier place for everyone. For nearly 20 years, Pharmaca has been a force for change in the world of natural health and beauty, empowering customers to think outside the box when it comes to the way they manage their own health and the products they use.
At the PHARMACIA, we are committed to exceeding the expectations of our patients by providing unparalleled caring and professional services and cost-effective products and solutions. We have created an environment of excellence, innovation and teamwork all dedicated to your wellness.
Enclara Pharmacia is a supplier of medications and clinical services. Move from Data to Decision. Enclarity TM is Enclara’s real-time dashboard and reporting tool. It delivers insight into utilization trends, industry benchmarks and pharmacy costs.
5331 pharmakeía (from pharmakeuō, "administer drugs") – properly, drug-related sorcery, like the practice of magical-arts, etc.
Kids & Baby. Lotion & Oils; Diapers & Training Pants; Baby Bottles; Vitamins & Supplements; Vitamins & Supplements; Bathing; Creams & Ointments; Pacifiers & Teething
The German Breast Group (GBG) and Pfizer Inc. (NYSE: PFE) today announced that the collaborative Phase 3 PENELOPE-B trial did not meet the primary endpoint of improved invasive disease-free survival (iDFS) in women with hormone receptor-positive (HR+), human epidermal growth factor-negative (HER2-) early breast cancer (eBC) who have residual invasive disease after completing neoadjuvant ...
“The reality of the spiritual origins of drug use that every serious Christian needs to know. Some of this I already understood, but linking the pieces together has made much more sense of the true picture, and it is a more dangerous situation than I had previously known.”